Safety Considerations for Patient Instructions to Minimize Medication Errors (9|9) Labeling 2017

Ebony Whaley, CDER Office of Surveillance and Epidemiology, discusses strategies and considerations for ensuring that instructions directed at patients (e.g. Instructions for Use, Quick Reference Guide) are designed to reduce or eliminate medication errors and to promote safe administration and use of drug products.

-------------------------

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming training and free continuing education credits:

CDER SBIA 2017 Playlist:
LinkedIn:
Training resources:

Twitter:

CDER small business e-mail update subscription:

Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367

REdI,CDER,FDA,SBIA,Labeling,PrescriptionDrugLabeling,